CAS Nr .: 2222844-89-3

Product Description:

Khoom npe: Camizestrant CAS 2222844-89-3

 

Synonyms:

N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,5-f]isoquinolin-6-yl]pyridin-3-amine

Estrogen receptor antagonist 2

 

 

Chemical & Physical Properties

Tsos: Tawm-dawb mus rau lub teeb daj Khoom

Kev Ntsuas: NLT98%

Boiling Point: 590.2℃(lit.)

Qhov ceev: 1.318g / cm3

npo: 14.25

 

 

Daim ntawv thov:

Camizestrant (developmental code AZD9833, trade name Etcamah) yog ib tug tom ntej no -generation oral selective estrogen receptor degrader (SERD) thiab tag nrho cov tshuaj estrogen receptor antagonist tsim los ntawm AstraZeneca.

 

 

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

 

 

Cov khoom raws li patent yog muab rau R & D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: Camizestrant CAS 2222844-89-3, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

• Tug: Ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS 1206124-13-1
• Tom ntej: (S)-3-(4-bromothiazole-2-yl)-2-((tertbutyloxycarbonyl)amino)propanoic Acidmethyl Ester CAS 2641451-73-0